CBL
Health Care Equipment & Services
Control Bionics
- Short interest
- 0.02%
- +0.01 pp 30d
- as of 13 Aug 2026
- Reported shorts
- 105.1K
- Shares on issue
- 543.089M
Control Bionics (CBL) company profile
Profile, insiders and operations
Company
AI-generated research profile of Control Bionics
Augmentative Communication
Assistive Technology
Bionics
Medical Devices
ASX
Control Bionics designs, manufactures, and sells augmentative and alternative communication (AAC) technology, enabling individuals with severe communication and physical challenges to interact and control devices using neural signals. Their product suite offers intuitive solutions for speech generation and device control, positioning them in the assistive technology market. The company aims to be a leading global provider of innovative communication and control devices.
Director trades
20 trades recorded
CBL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required